Clinical trial
Low-Dose Adjunctive Aripiprazole in the Treatment of Bipolar Depression: Double-Blind Placebo-Controlled Pilot Study
NCT01520350 is registered in ClinicalTrials.gov with Serge Beaulieu as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Low-Dose Adjunctive Aripiprazole in the Treatment of Bipolar Depression: Double-Blind Placebo-Controlled Pilot Study
- Lead sponsor
- Serge Beaulieu
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- February 29, 2012
- Completion date
- June 30, 2013
- Enrollment
- 2 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
bipolar disorder, depressive episode